An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
Recruiting · NCT07764146 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease | Alzheimer s Disease | Recruiting | Phase 1 | 2026-09-04 | NCT07764146 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Voyager Therapeutics | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| K2 Medical Research, LLC | Maitland | United States | 10 |